BioCentury
ARTICLE | Finance

Highline's hunter

How Versant's Highline incubator will fully bake its NYC newcos

April 18, 2016 7:00 AM UTC

Now that Versant Ventures' Highline Therapeutics has hired a veteran drug hunter and secured lab space in New York City, the incubator expects to be able to launch companies with fleshed out pipelines.

Last week, the firm named Joe Vacca CSO of Highline. Vacca was SVP of early success sharing partnerships at the WuXi AppTec unit of New WuXi Life Science Ltd. Before that he spent 30 years at Merck & Co. Inc. (NYSE:MRK). ...